e.l.f. Beauty, Inc. (ELF) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 5.49%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 5.49% | Share-based compensation / revenue. Period ending 2026-06-30. $96.73M ÷ $1.76B × 100 ≈ 5.49% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 1.76B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 96.73M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 127.36M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $1.76B | $96.73M | $127.36M | (m) | (m) | 5.49% | (m) | (m) |
| 2026-03-31 | (m) | $1.64B | $86.92M | $73.63M | (m) | (m) | 5.31% | (m) | (m) |
| 2025-12-31 | (m) | $1.52B | $84.05M | $168.28M | (m) | (m) | 5.53% | (m) | (m) |
| 2025-09-30 | (m) | $1.39B | $76.52M | $135.83M | (m) | (m) | 5.52% | (m) | (m) |
| 2025-06-30 | (m) | $1.34B | $68.69M | $156.03M | (m) | (m) | 5.12% | (m) | (m) |
| 2025-03-31 | (m) | $1.31B | $71.79M | $158.03M | (m) | (m) | 5.47% | (m) | (m) |
| 2024-12-31 | (m) | $1.30B | $68.12M | $130.74M | (m) | (m) | 5.23% | (m) | (m) |
| 2024-09-30 | (m) | $1.22B | $56.82M | $127.49M | (m) | (m) | 4.67% | (m) | (m) |
| 2024-06-30 | (m) | $1.13B | $46.39M | $139.75M | (m) | (m) | 4.10% | (m) | (m) |
| 2024-03-31 | (m) | $1.02B | $40.63M | $149.68M | (m) | (m) | 3.97% | (m) | (m) |
| 2023-12-31 | (m) | $890.15M | $36.74M | $140.69M | (m) | (m) | 4.13% | (m) | (m) |
| 2023-09-30 | (m) | $765.74M | $32.96M | $132.15M | (m) | (m) | 4.30% | (m) | (m) |
| 2023-06-30 | (m) | $672.58M | $29.77M | $107.35M | (m) | (m) | 4.43% | (m) | (m) |
| 2023-03-31 | (m) | $578.84M | $29.12M | $68.14M | (m) | (m) | 5.03% | (m) | (m) |
| 2022-12-31 | (m) | $496.62M | $26.88M | $62.28M | (m) | (m) | 5.41% | (m) | (m) |
| 2022-09-30 | (m) | $448.20M | $24.84M | $47.96M | (m) | (m) | 5.54% | (m) | (m) |
| 2022-06-30 | (m) | $417.71M | $21.91M | $40.03M | (m) | (m) | 5.24% | (m) | (m) |
| 2022-03-31 | (m) | $392.15M | $19.65M | $29.77M | (m) | (m) | 5.01% | (m) | (m) |
| 2021-12-31 | (m) | $379.69M | $19.24M | $25.72M | (m) | (m) | 5.07% | (m) | (m) |
| 2021-09-30 | (m) | $370.13M | $19.06M | $23.04M | (m) | (m) | 5.15% | (m) | (m) |
| 2021-06-30 | (m) | $350.63M | $19.34M | $17.56M | (m) | (m) | 5.51% | (m) | (m) |
| 2021-03-31 | (m) | $318.11M | $19.68M | $9.40M | (m) | (m) | 6.19% | (m) | (m) |
| 2020-12-31 | (m) | $300.15M | $19.25M | $12.31M | (m) | (m) | 6.41% | (m) | (m) |
| 2020-09-30 | (m) | $292.35M | $17.57M | $18.90M | (m) | (m) | 6.01% | (m) | (m) |
| 2020-06-30 | (m) | $287.61M | $16.19M | $26.03M | (m) | (m) | 5.63% | (m) | (m) |
| 2020-03-31 | (m) | $282.85M | $15.49M | $29.95M | (m) | (m) | 5.48% | (m) | (m) |
| 2019-12-31 | (m) | $274.28M | $14.96M | $9.90M | (m) | (m) | 5.46% | (m) | (m) |
| 2019-09-30 | (m) | $272.09M | $15.97M | $10.04M | (m) | (m) | 5.87% | (m) | (m) |
| 2019-06-30 | (m) | $268.37M | $16.16M | $7.25M | (m) | (m) | 6.02% | (m) | (m) |
| 2019-03-31 | (m) | $267.66M | $16.86M | $3.18M | (m) | (m) | 6.30% | (m) | (m) |
| 2018-12-31 | (m) | $267.44M | $16.82M | $26.16M | (m) | (m) | 6.29% | (m) | (m) |
| 2018-09-30 | (m) | $270.46M | $16.22M | $28.23M | (m) | (m) | 6.00% | (m) | (m) |
| 2018-06-30 | (m) | $278.43M | $15.81M | $31.70M | (m) | (m) | 5.68% | (m) | (m) |
| 2018-03-31 | (m) | $275.23M | $14.71M | $32.03M | (m) | (m) | 5.34% | (m) | (m) |
| 2017-12-31 | (m) | $269.89M | $13.47M | $33.28M | (m) | (m) | 4.99% | (m) | (m) |
| 2017-09-30 | (m) | $264.73M | $11.28M | $33.16M | (m) | (m) | 4.26% | (m) | (m) |
| 2017-06-30 | (m) | $249.18M | $11.93M | $24.86M | (m) | (m) | 4.79% | (m) | (m) |
| 2017-03-31 | (m) | $237.47M | $9.37M | $22.11M | (m) | (m) | 3.94% | (m) | (m) |
| 2016-12-31 | (m) | $229.57M | $7.15M | $23.08M | (m) | (m) | 3.11% | (m) | (m) |
| 2016-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | $213.04M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | $205.15M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | $191.41M | $503.00K | $25.57M | (m) | (m) | 0.26% | (m) | (m) |
| 2015-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTERPARFUMS INC (IPAR) | United States | $3.707B | 21.36 |
| COTY INC. (COTY) | United States | $2.307B | -3.15 |
| EDGEWELL PERSONAL CARE Co (EPC) | United States | $1.261B | -13.27 |
| SOLESENCE, INC. (SLSN) | United States | $0.058B | -25.13 |
| Axil Brands, Inc. (AXIL) | United States | $0.042B | 17.24 |
| UNITED GUARDIAN INC (UG) | United States | $0.034B | 13.30 |
| Caring Brands, Inc. (CABR) | United States | $0.013B | |
| BONK, INC. (BNKK) | United States | $0.011B | -0.14 |
| cbdMD, Inc. (YCBD) | United States | $0.005B | -2.59 |
| Kenvue Inc. (KVUE) | United States | $33.844B | 22.14 |